HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Nutrition, FDA Warning, OWL Board: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Abbott Nutrition sales flat; Texas herbal coop gets FDA warning; And CRN appoints OWL advisory board.

You may also be interested in...



Health, Beauty And Wellness Regulatory News: Warnings, Alerts, Recalls

Fourth recall of homeopathics linked to contaminated water; FDA posts alerts about Texas coop's products; and warnings note drug claims, GMP problems, same-site drug production.

CBD Cancer Claim Gets NAD Attention: Health And Wellness News

NAD sends CBD oil cancer claim to FTC; Supplement OWL passes 10,000 at first anniversary; Herbalife Nutrition two-for-one stock split; and Après resumes shipping with funding.

Supplement OWL Registry Counts On Peer Pressure To Spur Use

CRN-organized Supplement OWL launches with nearly 2,600 labels included and adds almost 500 more in its first week, though a much larger total is needed to offer drug store chains and other retailers access a broader perspective of products available in the US.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel